Centers for medicare & medicaid services (cms) codifies medicare coverage for ekso indego personal

Ruling could significantly expand use of ekso indego personal in home and community markets san rafael, calif., nov. 02, 2023 (globe newswire) -- ekso bionics holdings, inc. (nasdaq: ekso) (the “company”), an industry leader in exoskeleton technology for medical and industrial use, announces that the centers for medicare & medicaid services (“cms”) finalized its calendar year 2024 home health prospective payment system rule cms-1780 (“2024 home health rule”), which includes exoskeletons in the medicare brace benefit category.
EKSO Ratings Summary
EKSO Quant Ranking